IVF is selling for 1.14 as of the 24th of March 2025. This is a 0.88 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1.12. IVF has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Although IVF's alpha and beta are two of the key measurements used to evaluate IVF's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IVF stock to make a market-neutral strategy. Peer analysis of IVF could also be used in its relative valuation, which is a method of valuing IVF by comparing valuation metrics with similar companies.